Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Axion: Neural Activity Assay
In vitro neural models are a proven powerful strategy for the study of neural function and complex disorders of the human nervous system.
Organ Modelling
Axion: Neural Organoids
Three-dimensional induced pluripotent stem cell (iPSC)-derived in vitro cell models, commonly referred to as spheroids, organoids, or “mini-brains”, more accurately recapitulate the multicellular organization and structure of in vivo tissues when compared to traditional monolayer cell cultures
Target Discovery
Validation of an Impedance-based Cytotoxicity Assay for High Throughput Screening
High throughput screening requires careful validation of assay performance
Validation of a Structure-Function Assay for Neurotoxicity in Primary and hiPSC-Derived Neurons
Comprehensive, high-throughput, in vitro screening of the neurological effects of chemical compounds and drugs is vital for environmental and drug safety
Medicinal Chemistry
Interview with Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda
Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda, talks about working with regulators and the current regulatory paradigm.
Machine Learning for DNA Encoded Libraries
Our February Discovery Series discussion group centred on DNA Encoded Libraries (DEL). Using DEL enables the simultaneous screening of thousands of potential drugs against a target.
Target Discovery
Axion: Cardiac Activity Assay
In vitro models are a proven powerful strategy for studying disorders of the human heart.
Organ Modelling
Cellesce: Colorectal Cancer Organoid Lines
Cellesce’s technology enables the growth and expansion of Patient-Derived Organoids (PDOs)
Molecular Drug Design
Accuracy and Precision of Arrow Directionality in the Causaly Knowledge Graph
Causaly have developed an advanced machine-reading platform for semantic relationship extraction and comprehension
Target Discovery
Axion MEA Plates
When your research requires insightful, high-quality data from microelectrode arrays (MEAs), Axion BioSystems’ MEA plates provide the right balance of throughput, electrode count, and ease of use for your experiments.